Chronic graft-versus-host disease (GVHD) is a frequent and potentially life-threatening
complication of allogeneic hematopoietic stem cell transplantation. Increased …

Chronic graft versus host disease (cGVHD) is the most frequent long-term complication after
allogeneic stem cell transplantation (allo-SCT) and results in impaired quality of life and …

Chronic GVHD (cGVHD) is an important problem after allotransplants. Some risk factors for
cGVHD are similar to those of acute GVHD (aGVHD) but others are distinct indicating …

Herein we review current practice regarding the management of chronic graft-vs.-host
disease (cGvHD) in paediatric patients after allogeneic haematopoietic stem cell …

Chronic graft-vs-host-disease (cGvHD) is the most relevant long-term complication after
allogeneic stem cell transplantation (HSCT) with major impact on non-relapse mortality, but …

Chronic graft-versus-host disease (cGVHD) remains a major cause of morbidity and
mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Aim is to identify …

Endothelial activation and stress index (EASIX) predicts nonrelapse mortality (NRM) when
assessed before hematopoietic cell transplantation (HCT). We sought to determine whether …

Chronic graft versus host disease (cGvHD) is the most common cause of late morbidity and
mortality after allogeneic hematopoietic stem cell transplantation (HSCT). We retrospectively …

In this study, we aimed to modify the immune response in the long term after allogeneic
bone marrow transplantation (allo-BMT) by using the proteasome inhibitor ixazomib (IXZ) at …

Chronic graft-versus-host disease (cGVHD) is a significant complication after allogeneic
hematopoietic cell transplantation (allo-HCT)[1]. cGVHD remains the major cause of late non …